These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6351110)

  • 1. Erythrocyte carriers.
    Ihler GM
    Pharmacol Ther; 1983; 20(2):151-69. PubMed ID: 6351110
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of voltage pulses for the pore opening and drug loading, and the subsequent resealing of red blood cells.
    Tsong TY; Kinosita K
    Bibl Haematol; 1985; (51):108-14. PubMed ID: 4004753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier erythrocytes: an overview.
    Hamidi M; Tajerzadeh H
    Drug Deliv; 2003; 10(1):9-20. PubMed ID: 12554359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier erythrocytes. Clinical pharmacokinetic considerations.
    Tonetti M; De Flora A
    Clin Pharmacokinet; 1993 Nov; 25(5):351-7. PubMed ID: 8287630
    [No Abstract]   [Full Text] [Related]  

  • 5. [The role of erythrocytes in the system of controlled transport of pharmaceutical agents].
    Provotorov VM; Ivanova GA
    Klin Med (Mosk); 2009; 87(9):4-8. PubMed ID: 19882872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cells as carriers for drugs. A method for disseminating chemotherapeutics, hormones, enzymes and other therapeutic agents via the circulatory system. First International Conference on Red Blood Cell Carriers. Bellagio (Italy), February 27-March 2, 1984.
    Bibl Haematol; 1985; (51):1-162. PubMed ID: 4004751
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythrocyte-based drug delivery.
    Rossi L; Serafini S; Pierigé F; Antonelli A; Cerasi A; Fraternale A; Chiarantini L; Magnani M
    Expert Opin Drug Deliv; 2005 Mar; 2(2):311-22. PubMed ID: 16296756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osmotic fragility of drug carrier erythrocytes.
    Sprandel U; Zöllner N
    Res Exp Med (Berl); 1985; 185(1):77-85. PubMed ID: 3969524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte carriers.
    Ihler GM; Tsang HC
    Crit Rev Ther Drug Carrier Syst; 1985; 1(2):155-87. PubMed ID: 3913525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microparticulate systems for targeted drug delivery to phagocytes.
    Jhunjhunwala S; Little SR
    Cell Cycle; 2011 Jul; 10(13):2047-8. PubMed ID: 21623160
    [No Abstract]   [Full Text] [Related]  

  • 11. Encapsulation and targeting of drugs in electrically hemolysed red cells.
    Mishra KP; Patel MC; Ganatra RD; Singh BB
    Bibl Haematol; 1985; (51):115-26. PubMed ID: 4004754
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of the formed elements of the blood for the targeted delivery of chemotherapeutic and diagnostic preparations to the focus of the lesion].
    Gening TP; Kolker II; Zhumadilov ZhSh
    Antibiot Khimioter; 1988 Nov; 33(11):867-71. PubMed ID: 3067667
    [No Abstract]   [Full Text] [Related]  

  • 13. The function of adenosine deaminase in the human erythrocyte.
    Perrett D; Dean B
    Biochem Biophys Res Commun; 1977 Jul; 77(1):374-8. PubMed ID: 883983
    [No Abstract]   [Full Text] [Related]  

  • 14. Encapsulation of drugs in intact erythrocytes: an intravenous delivery system.
    Pitt E; Johnson CM; Lewis DA; Jenner DA; Offord RE
    Biochem Pharmacol; 1983 Nov; 32(22):3359-68. PubMed ID: 6651861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution.
    Rossi L; Pierigè F; Antonelli A; Bigini N; Gabucci C; Peiretti E; Magnani M
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):73-87. PubMed ID: 27189231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches to erythrocyte-mediated drug delivery.
    Magnani M; Rossi L
    Expert Opin Drug Deliv; 2014 May; 11(5):677-87. PubMed ID: 24547792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The binding of drugs with erythrocytes].
    Gneushev ET; Gneusheva IA
    Eksp Klin Farmakol; 1996; 59(5):71-5. PubMed ID: 9026220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carrier erythrocytes.
    DeLoach JR
    Med Res Rev; 1986; 6(4):487-504. PubMed ID: 3534487
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: Rachitic-like osseous changes in CID with absence of erythrocyte adenosine deaminase.
    Rosenfield RL
    J Pediatr; 1974 Sep; 85(3):442. PubMed ID: 4473728
    [No Abstract]   [Full Text] [Related]  

  • 20. Dynamic dialysis in drug-erythrocyte interactions.
    Parsons DL; Vallner JJ
    J Pharm Sci; 1979 May; 68(5):546-51. PubMed ID: 430488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.